Showing results (121-130 of 132) with videos related to
Sort By:
Pageof 14
Plos Neglected Tropical Diseases|September 7, 2018
Phylogenomic analysis unravels evolution of yellow fever virus within hostsChen Chen, Dong Jiang, Ming Ni, et al.Nature Communications|April 27, 2022
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 associationLin Zhu, Ting Gao, Yi Huang, et al.Science (New York, N.Y.)|April 24, 2020
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main proteaseWenhao Dai, Bing Zhang, Xia-Ming Jiang, et al.Signal Transduction and Targeted Therapy|March 5, 2024
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, et al.Cell Discovery|September 8, 2021
RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primatesXiaoyan Pan, Jian Shi, Xue Hu, et al.Nature|April 10, 2020
Structure of M<sup>pro</sup> from SARS-CoV-2 and discovery of its inhibitorsZhenming Jin, Xiaoyu Du, Yechun Xu, et al.Protein & Cell|February 2, 2023
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitorsYi Zang, Mingbo Su, Qingxing Wang, et al.Cell Research|June 11, 2021
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral targetBingqing Xia, Xurui Shen, Yang He, et al.Nature|April 22, 2025
Substrate recognition and cleavage mechanism of the monkeypox protease, Core proteaseYan Gao, Xiong Xie, Xiaoyu Zhang, et al.Cell Discovery|February 1, 2022
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunityYiru Long, Jianhua Sun, Tian-Zhang Song, et al.Pageof 14